<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101240003</journal-id>
<journal-id journal-id-type="pubmed-jr-id">32254</journal-id>
<journal-id journal-id-type="nlm-ta">Semin Fetal Neonatal Med</journal-id>
<journal-id journal-id-type="iso-abbrev">Semin Fetal Neonatal Med</journal-id>
<journal-title-group>
<journal-title>Seminars in fetal &amp; neonatal medicine</journal-title>
</journal-title-group>
<issn pub-type="ppub">1744-165X</issn>
<issn pub-type="epub">1878-0946</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">26851828</article-id>
<article-id pub-id-type="pmc">4798871</article-id>
<article-id pub-id-type="doi">10.1016/j.siny.2016.01.001</article-id>
<article-id pub-id-type="manuscript">NIHMS751542</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The genomics of prematurity in an era of more precise clinical phenotyping: a review</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Manuck</surname>
<given-names>Tracy A.</given-names>
</name>
<xref ref-type="aff" rid="A1">a</xref>
<xref ref-type="aff" rid="A2">b</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>a</label>Department of Obstetrics and Gynecology, Division of Maternal–Fetal Medicine, University of North Carolina – Chapel Hill, Chapel Hill, NC, USA</aff>
<aff id="A2"><label>b</label>Department of Obstetrics and Gynecology, Division of Maternal–Fetal Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA</aff>
<author-notes>
<corresp id="FN1"><label>*</label>Address: UNC Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, 3010 Old Clinic Building, CB#7516, Chapel Hill, NC 27599-7516, USA. Tel.: +1 919-966-1601; fax: +1 919-966-6377. <email>tmanuck@med.unc.edu</email></corresp>
<fn fn-type="conflict" id="FN2">
<p>
<bold>Conflict of interest statement</bold>
</p>
<p>None declared.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>15</day>
<month>1</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>03</day>
<month>2</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<month>4</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>4</month>
<year>2017</year>
</pub-date>
<volume>21</volume>
<issue>2</issue>
<fpage>89</fpage>
<lpage>93</lpage>
<!--elocation-id from pubmed: 10.1016/j.siny.2016.01.001-->
<abstract>
<title>SUMMARY</title>
<p id="P3">Spontaneous preterm birth is a major public health problem, with a clear genetic component. Genetic association studies have evolved substantially in recent years, moving away from the traditional candidate gene analyses to newer approaches utilizing sophisticated analysis platforms to examine sequencing data, and shifting towards functional studies including methylation analysis. It is becoming increasingly evident that careful clinical phenotyping is crucial to high quality genetic association studies regardless of the assay or platform being used. Nonetheless, genetic studies of prematurity are hampered by numerous challenges including small sample sizes, incomplete phenotying, population stratification, and multiple comparisons. As the costs of sequencing and functional analyses continue to decrease, unbiased genome-wide assays will be more widely available. Researchers have met improved success recently when critically applying clinical phenotyping knowledge to group women prior to analyzing genotyping results. Eventually, as the analytic approaches evolve, it is likely that this methodology (combining precisely clinically phenotyped subjects with genome-wide data) will provide key information regarding the pathophysiology of prematurity, and provide potential new avenues for exploring innovative therapeutic strategies.</p>
</abstract>
<kwd-group>
<kwd>Infant</kwd>
<kwd>Premature</kwd>
<kwd>Premature birth</kwd>
<kwd>Phenotype</kwd>
<kwd>Genetic predisposition</kwd>
<kwd>Polymorphism</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>